Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes
Get Live Data
2,469.00    -41.00 (-1.63%)
Bid:
2,472.00
Ask:
2,473.00
Spread: 1.00 (0.04%)
Market Cap: £7.41b
SMIN Live PriceLast checked at - London Stock Exchange

Intraday Smiths Group Share Chart

Share Buyback Programme

8 Apr 2022 07:00

RNS Number : 7163H
Smiths Group PLC
08 April 2022
 

8 April 2022

 

SMITHS GROUP PLC

 

SHARE BUYBACK PROGRAMME

 

Smith Group plc ("Smiths" or the "Company") announces that, in connection with the share buyback programme (the "Programme") of up to £742 million which it announced on 11 November 2021, Smiths will commence the third tranche of the Programme to purchase ordinary shares in the capital of the Company (the "Ordinary Shares") with a value of up to £200 million subject to remaining within the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its General Meeting on 17 November 2021 (the 2021 GM authority is for a maximum of 59,435,913 shares). The third tranche is expected to commence on 8 April 2022 and will end no later than 15 July 2022 (the "Engagement Period"). The purpose of the Programme is to reduce the share capital of Smiths.

 

The second tranche of the Programme ended within the previously announced engagement period on 4 April 2022. J.P. Morgan Securities plc, who undertook the second tranche for Smiths, purchased 5,126,307 shares for a total consideration of £74,999,992.25. To date, 14,753,663 shares have been purchased under the Programme, for a total consideration of £223,669,761.76.

 

The Company has entered into an agreement with Goldman Sachs International ("Goldman Sachs") under which Goldman Sachs will manage the third tranche of the Programme. Goldman Sachs will carry out the instruction through the acquisition of Ordinary Shares in the Company for subsequent repurchase and cancellation by the Company. This arrangement is in accordance with the Company's general authority to repurchase Ordinary Shares, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

Goldman Sachs may undertake transactions in the Company's Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by Goldman Sachs as a result of or as part of the Programme, but Goldman Sachs will continue to make any disclosures it is otherwise legally required to make.

 

 

Enquiries:

 

Jemma Spalton, Director of Communications & Investor Relations+44 (0)20 7004 1600

Jemma.splaton@smiths.com

Matthew Whyte, Company Secretary+44 (0)20 7004 1600Matthew.whyte@smiths.com

 

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

About Smiths Group

 

For over 170 years, Smiths Group has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets: Energy, General Industry, Security & Defence, and Aerospace. Listed on the London Stock Exchange, Smiths employs c. 14,600 colleagues in over 50 countries. For more information visit www.smiths.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAXLXEEFAEFA
Date   Source Headline
10th Oct 20255:35 pmRNSTransaction in Own Shares
9th Oct 20255:13 pmRNSTransaction in Own Shares
9th Oct 202512:00 pmRNSAnnual Financial Report
2nd Oct 202511:05 amRNSDirector/PDMR Shareholding
1st Oct 202510:45 amRNSTotal Voting Rights
24th Sep 20255:22 pmRNSTransaction in Own Shares
24th Sep 20253:30 pmRNSHolding(s) in Company
23rd Sep 20255:23 pmRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSSmiths Group FY25 Results Statement
22nd Sep 20255:12 pmRNSTransaction in Own Shares
19th Sep 20255:16 pmRNSTransaction in Own Shares
18th Sep 20255:18 pmRNSTransaction in Own Shares
17th Sep 20255:43 pmRNSTransaction in Own Shares
16th Sep 20255:24 pmRNSTransaction in Own Shares
15th Sep 20255:17 pmRNSTransaction in Own Shares
12th Sep 20255:24 pmRNSTransaction in Own Shares
11th Sep 20255:18 pmRNSTransaction in Own Shares
10th Sep 20255:16 pmRNSTransaction in Own Shares
9th Sep 20255:25 pmRNSTransaction in Own Shares
8th Sep 20255:46 pmRNSTransaction in Own Shares
5th Sep 20255:31 pmRNSTransaction in Own Shares
4th Sep 20256:27 pmRNSTransaction in Own Shares
3rd Sep 20255:19 pmRNSTransaction in Own Shares
2nd Sep 20256:00 pmRNSTransaction in Own Shares
1st Sep 20256:00 pmRNSHolding(s) in Company
1st Sep 20255:38 pmRNSTransaction in Own Shares
1st Sep 202510:45 amRNSTotal Voting Rights
29th Aug 20255:43 pmRNSTransaction in Own Shares
28th Aug 20256:04 pmRNSTransaction in Own Shares
28th Aug 202512:15 pmRNSHolding(s) in Company
28th Aug 20257:03 amRNSDirectorate Change
27th Aug 20255:59 pmRNSTransaction in Own Shares
26th Aug 20255:58 pmRNSTransaction in Own Shares
22nd Aug 20256:00 pmRNSTransaction in Own Shares
21st Aug 20256:10 pmRNSTransaction in Own Shares
20th Aug 20256:04 pmRNSTransaction in Own Shares
19th Aug 20256:04 pmRNSTransaction in Own Shares
18th Aug 20256:08 pmRNSTransaction in Own Shares
15th Aug 20255:14 pmRNSTransaction in Own Shares
14th Aug 20255:11 pmRNSTransaction in Own Shares
13th Aug 20255:11 pmRNSTransaction in Own Shares
12th Aug 20255:17 pmRNSTransaction in Own Shares
11th Aug 20255:11 pmRNSTransaction in Own Shares
8th Aug 20255:22 pmRNSTransaction in Own Shares
7th Aug 20255:38 pmRNSTransaction in Own Shares
7th Aug 20253:30 pmRNSHolding(s) in Company
6th Aug 20255:24 pmRNSTransaction in Own Shares
5th Aug 20255:26 pmRNSTransaction in Own Shares
4th Aug 20255:11 pmRNSTransaction in Own Shares
1st Aug 20255:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.